Skip to main content

Advertisement

Log in

The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

The evidence regarding association between thyroid disorders and benign and malignant breast diseases is increasing. The studies exploring the relationship between thyroid and breast diseases usually have focused on thyroid autoimmunity and functions in patients with breast pathologies. In this study, we aimed to reveal the frequency of benign breast conditions in patients with nodular thyroid disease (NTD) and Hashimoto’s thyroiditis (HT).

Methods

Seventy-one women with NTD, ninety-five women with HT and seventy-two healthy people as a control group were included in the study. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and thyroid peroxidase autoantibody levels were measured, and thyroid and breast ultrasonography were performed by a single operator in order to determine thyroid and breast pathology.

Results

Benign breast diseases were detected in 54.9 % of patients with NTD, in 47.4 % of those with HT, and 29.2 % of control group in the study (p < 0.01 for nodular and Hashimoto groups versus control group). Simple cyst was found to be the most frequent pathology among benign breast diseases; fibrocystic changes, mixed lesions, benign solid mass, ductal ectasia, and complex cyst followed it. No significant relation was found regarding thyroid function and autoimmunity in patients diagnosed with benign breast disease (p > 0.05).

Conclusions

The results of our study support the association between benign breast diseases and thyroid diseases. An important implication of this finding may be demonstration of the necessity of scanning for potential breast pathology in women with nodular or autoimmune thyroid disease in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478

    Chapter  Google Scholar 

  2. Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128

    Article  CAS  PubMed  Google Scholar 

  3. Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649

    Article  CAS  PubMed  Google Scholar 

  4. Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705

    Article  CAS  PubMed  Google Scholar 

  5. Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765

    Article  CAS  PubMed  Google Scholar 

  6. Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340

    Article  CAS  PubMed  Google Scholar 

  7. Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856

    Article  PubMed  Google Scholar 

  8. Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269

    Chapter  Google Scholar 

  9. Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994

    CAS  PubMed  Google Scholar 

  10. Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716

    CAS  PubMed  Google Scholar 

  11. Macfarlane IA, Robinson EL, Bush H et al (1980) Thyroid function in patients with benign and malignant breast disease. Br J Cancer 41:478–480

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093

    Article  PubMed  Google Scholar 

  13. Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688

    Article  CAS  PubMed  Google Scholar 

  14. Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177

    Article  CAS  PubMed  Google Scholar 

  15. Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133

    Article  CAS  PubMed  Google Scholar 

  16. Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352

    Article  CAS  PubMed  Google Scholar 

  17. Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610

    PubMed  Google Scholar 

  18. Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714

    Article  CAS  PubMed  Google Scholar 

  19. Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671

    PubMed Central  PubMed  Google Scholar 

  20. Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237

    PubMed  Google Scholar 

  21. Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Anil.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anil, C., Guney, T. & Gursoy, A. The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis. J Endocrinol Invest 38, 971–975 (2015). https://doi.org/10.1007/s40618-015-0269-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-015-0269-8

Keywords

Navigation